PRME - Prime Medicine Inc
4.05
-0.060 -1.481%
Share volume: 2,250,167
Last Updated: 03-10-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$4.11
-0.06
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-10-2024 | 08-08-2024 | 11-12-2024 | 02-28-2025 | 05-08-2025 | 11-07-2025 | 03-03-2026 | |
| Cash flow financing | 157.327 M | 35.000 K | 38.513 M | 1.000 K | 6.000 M | 144.753 M | 562.000 K | |
| Other financing cash flows | 6.036 M | 35.000 K | 32.000 K | 0.000 | 6.000 M | 6.373 M | 408.000 K | |
| Cash flow | 52.588 M | -38.562 M | 62.943 M | 64.499 M | -90.599 M | 17.592 M | -8.364 M | |
| Net income | -45.761 M | -55.327 M | -52.518 M | -42.276 M | -51.890 M | -50.582 M | -46.079 M | |
| Depreciation | 1.315 M | 1.538 M | 1.558 M | 1.717 M | 1.700 M | 1.881 M | 1.876 M | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -37.032 M | 6.894 M | 50.342 M | 48.253 M | -47.742 M | -92.122 M | 28.330 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 724.000 K | 276.000 K | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 2.324 M | 1.902 M | 1.277 M | 1.791 M | 2.422 M | 247.000 K | 290.000 K | |
| Cash Change | 52.588 M | -38.562 M | 62.943 M | 64.499 M | -90.599 M | 17.592 M | -8.364 M |